roche__tree

Roche confirms over 200 job cuts at Irish facility

pharmafile | May 18, 2016 | News story | Manufacturing and Production Roche, clare, clarecastle, closure, irish site, job cuts, job losses 

Swiss pharmaceutical company Roche (VTX: ROG) has confirmed that 240 jobs are to go at their Irish site in Clare, which is set to close by 2019.

The company had originally announced its intention to leave the site late last year, but indicated that it would attempt to transfer the plant to a global pharma services company. These negotiations, however, were unsuccessful.

The facility in Clarecastle has been operational since 1974, and is Roche’s only operational presence in Ireland.

Advertisement

A company statement sad that all production at the site will “cease in a phased approach currently estimated to be completed between 2018 and 2019 when Roche will exit the site.”

The company will now enter into consultation with staff and their representatives going forward. The closure of the Irish site comes as Roche looks to focus its attention on a “new generation of specialised medicines”.

Sean Murray

Related Content

alzheimers_brain

Roche receives CE Mark for blood test to help rule out Alzheimer’s

Roche has been granted CE Mark approval for its Elecsys pTau181 test, the first in …

blood_test

Roche candidate shows early promise for treating haemophilia A

Roche has announced encouraging early results from its phase 1/2 trial of NXT007, an investigational …

Roche advances treatment for Parkinson’s disease

Swiss biopharma, Roche, has announced its decision to proceed with phase 3 trials of prasinezumab, …

The Gateway to Local Adoption Series

Latest content